<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK1195" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK1195/" /><meta name="ncbi_pagename" content="Succinic Semialdehyde Dehydrogenase Deficiency - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Succinic Semialdehyde Dehydrogenase Deficiency - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Succinic Semialdehyde Dehydrogenase Deficiency" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2016/04/28" /><meta name="citation_author" content="Phillip L Pearl" /><meta name="citation_author" content="Natrujee Wiwattanadittakul" /><meta name="citation_author" content="Jean-Baptiste Roullet" /><meta name="citation_author" content="K Michael Gibson" /><meta name="citation_pmid" content="20301374" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK1195/" /><meta name="citation_keywords" content="4-Hydroxybutyric Aciduria" /><meta name="citation_keywords" content="Gamma-Hydroxybutyric Aciduria" /><meta name="citation_keywords" content="SSADH Deficiency" /><meta name="citation_keywords" content="4-Hydroxybutyric Aciduria" /><meta name="citation_keywords" content="Gamma-Hydroxybutyric Aciduria" /><meta name="citation_keywords" content="SSADH Deficiency" /><meta name="citation_keywords" content="Succinate-semialdehyde dehydrogenase, mitochondrial" /><meta name="citation_keywords" content="ALDH5A1" /><meta name="citation_keywords" content="Succinic Semialdehyde Dehydrogenase Deficiency" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Succinic Semialdehyde Dehydrogenase Deficiency" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Phillip L Pearl" /><meta name="DC.Contributor" content="Natrujee Wiwattanadittakul" /><meta name="DC.Contributor" content="Jean-Baptiste Roullet" /><meta name="DC.Contributor" content="K Michael Gibson" /><meta name="DC.Date" content="2016/04/28" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK1195/" /><meta name="description" content="Succinic semialdehyde dehydrogenase (SSADH) deficiency is characterized by infantile-onset hypotonia, developmental delay, cognitive impairment, expressive language deficit, and mild ataxia. Epilepsy is present in about half of affected individuals and is more common in adults. Hyperkinetic behavior, aggression, self-injurious behaviors, hallucinations, and sleep disturbances have been reported in nearly half of all affected individuals, more commonly in those who are older. Basal ganglia signs including choreoathetosis, dystonia, and myoclonus have been reported in a few individuals with earlier-onset, more severe disease. Involvement beyond the central nervous system has not been described." /><meta name="og:title" content="Succinic Semialdehyde Dehydrogenase Deficiency" /><meta name="og:type" content="book" /><meta name="og:description" content="Succinic semialdehyde dehydrogenase (SSADH) deficiency is characterized by infantile-onset hypotonia, developmental delay, cognitive impairment, expressive language deficit, and mild ataxia. Epilepsy is present in about half of affected individuals and is more common in adults. Hyperkinetic behavior, aggression, self-injurious behaviors, hallucinations, and sleep disturbances have been reported in nearly half of all affected individuals, more commonly in those who are older. Basal ganglia signs including choreoathetosis, dystonia, and myoclonus have been reported in a few individuals with earlier-onset, more severe disease. Involvement beyond the central nervous system has not been described." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK1195/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/ssadh/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK1195/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE885F36E0403981000000000389011E.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK1195_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK1195_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/stickler/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/iiae3/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK1195_"><span class="title" itemprop="name">Succinic Semialdehyde Dehydrogenase Deficiency</span></h1><div itemprop="alternativeHeadline" class="subtitle whole_rhythm">Synonyms: 4-Hydroxybutyric Aciduria, Gamma-Hydroxybutyric Aciduria, SSADH Deficiency</div><p class="contrib-group"><span itemprop="author">Phillip L Pearl</span>, MD, <span itemprop="author">Natrujee Wiwattanadittakul</span>, MD, <span itemprop="author">Jean-Baptiste Roullet</span>, PhD, and <span itemprop="author">K Michael Gibson</span>, PhD, FACMG.</p><a data-jig="ncbitoggler" href="#__NBK1195_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK1195_ai__"><div class="contrib half_rhythm"><span itemprop="author">Phillip L Pearl</span>, MD<div class="affiliation small">Professor of Neurology, Boston Children&#x02019;s Hospital<br />Harvard Medical School<br />Boston, Massachusetts<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.dravrah.snerdlihc@lraep.pillihp" class="oemail">ude.dravrah.snerdlihc@lraep.pillihp</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Natrujee Wiwattanadittakul</span>, MD<div class="affiliation small">Faculty of Medicine<br />Chiang Mai University<br />Chiang Mai, Thailand<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="moc.liamg@w.eejurtan" class="oemail">moc.liamg@w.eejurtan</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Jean-Baptiste Roullet</span>, PhD<div class="affiliation small">Professor, College of Pharmacology<br />Washington State University<br />Spokane, Washington<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.usw@telluor.j" class="oemail">ude.usw@telluor.j</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">K Michael Gibson</span>, PhD, FACMG<div class="affiliation small">Professor and Head, Section of Clinical Pharmacology<br />College of Pharmacy<br />Washington State University<br />Spokane, Washington<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.usw@nosbig.ekim" class="oemail">ude.usw@nosbig.ekim</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">May 5, 2004</span>; Last Update: <span itemprop="dateModified">April 28, 2016</span>.</p><p><em>Estimated reading time: 18 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="ssadh.Summary" itemprop="description"><h2 id="_ssadh_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>Succinic semialdehyde dehydrogenase (SSADH) deficiency is characterized by infantile-onset hypotonia, developmental delay, cognitive impairment, expressive language deficit, and mild ataxia. Epilepsy is present in about half of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals and is more common in adults. Hyperkinetic behavior, aggression, self-injurious behaviors, hallucinations, and sleep disturbances have been reported in nearly half of all affected individuals, more commonly in those who are older. Basal ganglia signs including choreoathetosis, dystonia, and myoclonus have been reported in a few individuals with earlier-onset, more severe disease. Involvement beyond the central nervous system has not been described.</p><p>Individuals with SSADH deficiency typically have 4-hydroxybutyric aciduria present on urine organic acid analysis. Head MRI reveals T<sub>2</sub> hyperintensities in multiple regions, involving the globus pallidi, cerebellar dentate nuclei, subthalamic nuclei, subcortical white matter, and brain stem, as well as cerebral and sometimes cerebellar atrophy. EEG findings include background slowing and spike discharges that are usually generalized.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis of SSADH deficiency is established by the identification of <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>ALDH5A1</i>.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Management is most often symptomatic, directed at the treatment of seizures and neurobehavioral disturbances. A broad spectrum of antiepileptic medication has been used to treat this condition. While vigabatrin is an irreversible inhibitor of GABA-transaminase and thus inhibits the formation of succinic semialdehyde, it has shown inconsistent results in treatment of seizures associated with SSADH deficiency. Methylphenidate, thioridazine, risperidal, fluoxetine, and benzodiazepines have been used for treatment of increased anxiety, aggressiveness, and inattention. Additional, non-pharmacologic treatments may include physical and occupational therapy, sensory integration, feeding and/or speech therapy.</p><p><i>Surveillance:</i> Regular neurologic and developmental assessments as indicated.</p><p><i>Agents/circumstances to avoid:</i> Valproate may inhibit residual SSADH enzyme activity; however, valproate may be considered in individuals with refractory epilepsy who have failed other treatments.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>SSADH deficiency is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner. At conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier. Carrier testing for at-risk relatives is possible if the pathogenic variants have been identified in the family. Biochemical testing is not accurate or reliable for carrier determination. Prenatal diagnosis for pregnancies at increased risk is possible using <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> if the pathogenic variants have been identified in the family, or using biochemical testing (either measurement of 4-hydroxybutyric acid in amniotic fluid or assay of SSADH enzyme activity in chorionic villus tissue and cultured amniocytes).</p></div></div><div id="ssadh.Diagnosis"><h2 id="_ssadh_Diagnosis_">Diagnosis</h2><div id="ssadh.Suggestive_Findings"><h3>Suggestive Findings</h3><p>Succinic semialdehyde dehydrogenase (SSADH) deficiency <b>should be suspected</b> in individuals with the following clinical, imaging, EEG, and supportive laboratory findings:</p><p><b>Clinical features.</b> Late-infantile to early-childhood onset, slowly progressive or static encephalopathy characterized by:</p><ul><li class="half_rhythm"><div>Cognitive deficiency</div></li><li class="half_rhythm"><div>Prominent expressive language deficit</div></li><li class="half_rhythm"><div>Hypotonia</div></li><li class="half_rhythm"><div>Epilepsy</div></li><li class="half_rhythm"><div>Hyporeflexia</div></li><li class="half_rhythm"><div>Ataxia</div></li></ul><p><b>Neuroimaging features</b></p><ul><li class="half_rhythm"><div>Cranial MRI that demonstrates:</div><ul><li class="half_rhythm"><div>A pallidodentatoluysian pattern [<a class="bk_pop" href="#ssadh.REF.pearl.2009c.184">Pearl et al 2009c</a>], showing increased T<sub>2</sub>-weighted signal involving the globus pallidi bilaterally and symmetrically, in addition to the cerebellar dentate nuclei and subthalamic nuclei</div></li><li class="half_rhythm"><div>T<sub>2</sub>-hyperintensities of subcortical white matter and brain stem</div></li><li class="half_rhythm"><div>Cerebral atrophy</div></li><li class="half_rhythm"><div>Cerebellar atrophy</div></li><li class="half_rhythm"><div>Delayed myelination</div></li></ul></li><li class="half_rhythm"><div>Magnetic resonance spectroscopy that demonstrates elevated levels of GABA and related compounds in the Glx peak (e.g., GHB [gammahydroxybutyrate, also known as 4-hydroxybutyric acid], glutamate, and homocarnosine)</div></li></ul><p><b>EEG findings.</b> Background slowing and spike discharges that are usually generalized. Note: EEG studies are normal in about one third of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p><p><b>Supportive laboratory findings</b></p><ul><li class="half_rhythm"><div>Absence of metabolic acidosis</div></li><li class="half_rhythm"><div>Urine organic acid analysis</div><ul><li class="half_rhythm"><div>4-hydroxybutyric acid concentration of 100-1200 mmol/mol creatinine (normal: &#x0003e;0-7 mmol/mol creatinine)</div></li><li class="half_rhythm"><div>Note: (1) Specific ion monitoring may be required for the detection of this metabolite, as its presence is sometimes obscured by a large normal urea peak on routine organic acid qualitative studies [<a class="bk_pop" href="#ssadh.REF.pearl.2003.1413">Pearl et al 2003</a>]; (2) falsely elevated urinary concentrations of 4-hydroxybutyric acid (GHB) have been reported in individuals in whom the urine sample was obtained using Coloplast SpeediCath catheters, which have been found to have GHB concentrations as high as 11 mmol/L [<a class="bk_pop" href="#ssadh.REF.wamelink.2011.216">Wamelink et al 2011</a>].</div></li><li class="half_rhythm"><div>Small amounts of 4,5-dihydroxyhexanoic acid and 3-hydroxyproprionic acid and significant amounts of dicarboxylic acids may be detected. Urine organic acids can be confusing with the presence of elevated levels of d-2-hydroxyglutaric acid, but in the routine organic acid analysis this will only be reported as 2-hydroxyglutaric acid.</div></li><li class="half_rhythm"><div>Increased glycine concentration</div></li></ul></li><li class="half_rhythm"><div>Plasma amino/organic acid analysis</div><ul><li class="half_rhythm"><div>4-hydroxybutyric acid concentration of 35-600 &#x000b5;mol/L (normal: 0-3 &#x000b5;mol/L)</div></li><li class="half_rhythm"><div>Increased glycine concentration</div></li></ul></li><li class="half_rhythm"><div>Cerebrospinal fluid (CSF) analysis</div><ul><li class="half_rhythm"><div>4-hydroxybutyric acid concentration of 100-850 &#x000b5;mol/L (normal: 0-2 &#x000b5;mol/L)</div></li><li class="half_rhythm"><div>A transient increase in CSF glycine concentration</div></li><li class="half_rhythm"><div>Elevated free and total GABA and homocarnosine concentrations coupled to lowered glutamine</div></li></ul></li></ul><p>Note: Newborn screening is not routinely done for this disorder at this time.</p></div><div id="ssadh.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The diagnosis of SSADH deficiency <b>is established</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> by the identification of <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>ALDH5A1</i> on <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> (see <a class="figpopup" href="/books/NBK1195/table/ssadh.T.molecular_genetic_testing_used_i/?report=objectonly" target="object" rid-figpopup="figssadhTmoleculargenetictestingusedi" rid-ob="figobssadhTmoleculargenetictestingusedi">Table 1</a>).</p><p>Molecular testing approaches can include <b>single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b> or use of a <b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b>:</p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing.</b> Sequence analysis of <i>ALDH5A1</i> is performed first, followed by gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> if only one or no <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is found.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>A <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes <i>ALDH5A1</i> and other genes of interest (see <a href="#ssadh.Differential_Diagnosis">Differential Diagnosis</a>) may also be considered. Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>; thus, clinicians need to determine which multigene panel is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. (3) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests.</div><div class="half_rhythm">For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</div></li></ul><div id="ssadh.T.molecular_genetic_testing_used_i" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in Succinic Semialdehyde Dehydrogenase Deficiency</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1195/table/ssadh.T.molecular_genetic_testing_used_i/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__ssadh.T.molecular_genetic_testing_used_i_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_ssadh.T.molecular_genetic_testing_used_i_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_ssadh.T.molecular_genetic_testing_used_i_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Test Method</th><th id="hd_h_ssadh.T.molecular_genetic_testing_used_i_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of Probands with Pathogenic Variants&#x000a0;<sup>2</sup> Detectable by This Method</th></tr></thead><tbody><tr><td headers="hd_h_ssadh.T.molecular_genetic_testing_used_i_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>ALDH5A1</i></td><td headers="hd_h_ssadh.T.molecular_genetic_testing_used_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>3</sup></td><td headers="hd_h_ssadh.T.molecular_genetic_testing_used_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">97%&#x000a0;<sup>4</sup></td></tr><tr><td headers="hd_h_ssadh.T.molecular_genetic_testing_used_i_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>5</sup></td><td headers="hd_h_ssadh.T.molecular_genetic_testing_used_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown&#x000a0;<sup>6</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="ssadh.TF.1.1"><p class="no_margin">See <a href="/books/NBK1195/#ssadh.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="ssadh.TF.1.2"><p class="no_margin">See <a href="#ssadh.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>3. </dt><dd><div id="ssadh.TF.1.3"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>4. </dt><dd><div id="ssadh.TF.1.4"><p class="no_margin">Sixty-two families [<a class="bk_pop" href="#ssadh.REF.liu.2016.441">Liu et al 2016</a>]</p></div></dd><dt>5. </dt><dd><div id="ssadh.TF.1.5"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods used may include: <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications.</p></div></dd><dt>6. </dt><dd><div id="ssadh.TF.1.6"><p class="no_margin"><a class="bk_pop" href="#ssadh.REF.kwok.2012.280">Kwok et al [2012]</a> reported a novel 34-bp <a class="def" href="/books/n/gene/glossary/def-item/insertion/">insertion</a> in <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 10 that resulted in a pathogenic <a class="def" href="/books/n/gene/glossary/def-item/frameshift-variant/">frameshift variant</a> leading to a truncated SSADH protein lacking 50 amino acids in the C-terminus.</p></div></dd></dl></div></div></div></div></div><div id="ssadh.Clinical_Characteristics"><h2 id="_ssadh_Clinical_Characteristics_">Clinical Characteristics</h2><div id="ssadh.Clinical_Description"><h3>Clinical Description</h3><p>SSADH deficiency is characterized by a relatively non-progressive encephalopathy presenting with hypotonia and delayed acquisition of motor and language developmental milestones in the first two years of life. Common clinical features include intellectual disability, behavior problems, and motor dysfunction.</p><p>Symptoms are first reported at a mean age of 11 months (range 0-44 months) and the mean age at diagnosis is 6.6 years (range 0-25 years) [<a class="bk_pop" href="#ssadh.REF.pearl.2009a.343">Pearl et al 2009a</a>]. One study reported an adult man who was diagnosed in the sixth decade of life [<a class="bk_pop" href="#ssadh.REF.lapalmeremis.2015.861">Lapalme-Remis et al 2015</a>]. Psychiatric symptoms may be the most disabling; they include sometimes prominent ADHD and even aggression in early childhood, and anxiety and obsessive-compulsive disorder in adolescence and adulthood [<a class="bk_pop" href="#ssadh.REF.pearl.2004.107">Pearl &#x00026; Gibson 2004</a>, <a class="bk_pop" href="#ssadh.REF.knerr.2008.598">Knerr et al 2008</a>].</p><p>Affected individuals do not usually have episodic decompensation following metabolic stressors as is typical of other organic acidemias and metabolic encephalopathies, although some have been diagnosed after having unanticipated difficulty recovering from otherwise ordinary childhood illnesses. Clinical presentation with acute onset of generalized hypotonia and choreiform movement following upper-respiratory tract infection has been reported [<a class="bk_pop" href="#ssadh.REF.wang.2016.1305">Wang et al 2016</a>].</p><p>Approximately 10% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals have a more severe <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> including early-onset prominent extrapyramidal manifestations and a regressive course [<a class="bk_pop" href="#ssadh.REF.pearl.2005b.1051">Pearl et al 2005b</a>].</p><p><b>Seizures.</b> Half of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals have epilepsy, usually with generalized tonic-clonic or atypical absence seizures [<a class="bk_pop" href="#ssadh.REF.pearl.2003.1413">Pearl et al 2003</a>]. Epilepsy is more common in adults, and may be progressive [<a class="bk_pop" href="#ssadh.REF.lapalmeremis.2015.861">Lapalme-Remis et al 2015</a>]. In one family two heterozygotes for SSADH deficiency (one parent and a sib of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with the disorder) had generalized spike-wave discharges, photosensitivity, and absence and myoclonic seizures [<a class="bk_pop" href="#ssadh.REF.dervent.2004.1417">Dervent et al 2004</a>].</p><p><b>Sleep disorders</b> are common and manifest either as excessive daytime somnolence or as disorders of initiating or maintaining sleep [<a class="bk_pop" href="#ssadh.REF.philippe.2004.564">Philippe et al 2004</a>, <a class="bk_pop" href="#ssadh.REF.arnulf.2005.418">Arnulf et al 2005</a>]. Ten <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals studied with overnight polysomnography and daytime multiple sleep latency testing (MLST) had prolonged REM latency (mean 272&#x000b1;89 min) and reduced stage REM percentage (mean 8.9%, range 0.3%-13.8%) [<a class="bk_pop" href="#ssadh.REF.pearl.2009b.1645">Pearl et al 2009b</a>]. Half of these individuals showed a decrease in daytime mean sleep latency on MSLT, indicating excessive daytime somnolence. Overall, REM sleep appears to be reduced.</p><p><b>Neuropathology</b> from one individual with a confirmed diagnosis revealed discoloration of the globus pallidus and leptomeningeal congestion on gross pathology. On microscopic examination, hyperemia and granular perivascular calcification of the globus pallidus and superior colliculus were identified, and interpreted as consistent with chronic excitotoxic injury. There was not significant neuronal loss or gliosis of CA1 of the hippocampus, the area that would have been considered most vulnerable to epileptic or hypoxic injury in this individual, who died with a clinical diagnosis of SUDEP (sudden unexpected death in epilepsy patients) after having had escalating seizures [<a class="bk_pop" href="#ssadh.REF.knerr.2010.255">Knerr et al 2010</a>]. The authors are aware of two additional <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals who had SUDEP [Authors, unpublished data].</p></div><div id="ssadh.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>No <a class="def" href="/books/n/gene/glossary/def-item/genotype-phenotype-correlations/">genotype-phenotype correlations</a> have been observed.</p></div><div id="ssadh.Prevalence"><h3>Prevalence</h3><p>Approximately 450 individuals have been diagnosed with SSADH deficiency [<a class="bk_pop" href="#ssadh.REF.gibson.2001">Gibson &#x00026; Jakobs 2001</a>; Gibson &#x00026; Jakobs, personal communication], but it has been estimated to occur in 1:1,000,000 individuals [KM Gibson, unpublished data].</p><p>Because of the nonspecific nature of SSADH deficiency and the related difficulty in diagnosing <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals, the disorder may be significantly underdiagnosed. Thus, the true prevalence is unknown [<a class="bk_pop" href="#ssadh.REF.pearl.2003.1413">Pearl et al 2003</a>].</p><p>Parental <a class="def" href="/books/n/gene/glossary/def-item/consanguinity/">consanguinity</a> has been reported in approximately 40% of all published cases [<a class="bk_pop" href="#ssadh.REF.gibson.1997a.567">Gibson et al 1997a</a>, <a class="bk_pop" href="#ssadh.REF.gibson.1997b.370">Gibson et al 1997b</a>, <a class="bk_pop" href="#ssadh.REF.alessa.2000.127">Al-Essa et al 2000</a>, <a class="bk_pop" href="#ssadh.REF.yal_inkaya.2000.45">Yal&#x000e7;inkaya et al 2000</a>].</p></div></div><div id="ssadh.Genetically_Related_Allelic_Disord"><h2 id="_ssadh_Genetically_Related_Allelic_Disord_">Genetically Related (Allelic) Disorders</h2><p>No phenotypes other than those described in this <i>GeneReview</i> are known to be associated with pathogenic variants in <i>ALDH5A1</i>.</p><p>One family (3 <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals) with developmental delay and a small <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> involving <i>ALDH5A1</i> has been described [<a class="bk_pop" href="#ssadh.REF.siggberg.2011.448">Siggberg et al 2011</a>]. Elevated SSADH enzymatic activity in the affected individuals was confirmed in cultured white blood cells and may have a negative impact on GABA metabolism, possibly leading or contributing to the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> (see <a href="#ssadh.Molecular_Genetics">Molecular Genetics</a>).</p></div><div id="ssadh.Differential_Diagnosis"><h2 id="_ssadh_Differential_Diagnosis_">Differential Diagnosis</h2><p>Other disorders of GABA metabolism:</p><ul><li class="half_rhythm"><div><b>4-aminobutyrate aminotransferase (GABA-transaminase, GABA-T) deficiency</b> (OMIM <a href="http://omim.org/entry/613163" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">613163</a>). GABA transaminase deficiency was first reported in an index sibship and an additional unrelated <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> [<a class="bk_pop" href="#ssadh.REF.medinakauwe.1999.414">Medina-Kauwe et al 1999</a>], and then in an infant identified using MR spectroscopy [<a class="bk_pop" href="#ssadh.REF.tsuji.2010.85">Tsuji et al 2010</a>]. The <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> is characterized by psychomotor retardation, hypotonia, hyperreflexia, lethargy, refractory seizures of neonatal or infantile onset, agenesis of the corpus callosum, and cerebellar hypoplasia. Additional cases are being recognized especially with increased use of <a class="def" href="/books/n/gene/glossary/def-item/next-generation-sequencing/">next-generation sequencing</a> [<a class="bk_pop" href="#ssadh.REF.besse.2015.417">Besse et al 2015</a>]. Free and total GABA concentration levels are elevated in the CSF, without elevation in GHB. Biallelic pathogenic variants in <i>ABAT</i> are causative. Inheritance is <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a>.</div></li><li class="half_rhythm"><div><b>Homocarnosinosis</b> (OMIM <a href="http://omim.org/entry/236130/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">236130</a>). Homocarnosine is a dipeptide of histidine and GABA. A single case of primary homocarnosinosis has been reported; the enzyme defect has not been conclusively proven [<a class="bk_pop" href="#ssadh.REF.gibson.2001">Gibson &#x00026; Jakobs 2001</a>].</div></li></ul><p>SSADH deficiency cannot easily be differentiated clinically from other disorders that cause intellectual disability. Screening by urine organic acid analysis is necessary to detect SSADH deficiency.</p><p>Elevated glycine can be seen in <a href="/books/n/gene/nkh/">glycine encephalopthy</a> (non-ketotic hyperglycinemia), which is distinguished from SSADH based on the absence of GHB in individuals with glycine encephalopathy.</p><p>Abnormal signal bilaterally in the globus pallidus can be seen in other organic acidurias, particularly methylmalonic aciduria (see <a href="/books/n/gene/mma/">Methylmalonic Acidemia</a>), mitochondrial disorders (see <a href="/books/n/gene/mt-overview/">Mitochondrial Disorders Overview</a>), <a href="/books/n/gene/pkan/">pantothenate kinase-associated neurodegeneration</a> (PKAN), and <a href="/books/n/gene/neuroferritin/">neuroferritinopathy</a> [<a class="bk_pop" href="#ssadh.REF.curtis.2001.350">Curtis et al 2001</a>].</p><p>Unlike other metabolic encephalopathies and some other organic acidurias, SSADH deficiency does not usually present with metabolic stroke, megalencephaly, episodic hypoglycemia, hyperammonemia, acidosis, or intermittent decompensation [<a class="bk_pop" href="#ssadh.REF.pearl.2003.1413">Pearl et al 2003</a>].</p></div><div id="ssadh.Management"><h2 id="_ssadh_Management_">Management</h2><div id="ssadh.Evaluations_Following_Initial_Diag"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in an individual diagnosed with succinic semialdehyde dehydrogenase (SSADH) deficiency, the following evaluations are recommended:</p><ul><li class="half_rhythm"><div>Neuroimaging (MRI)</div></li><li class="half_rhythm"><div>EEG</div></li><li class="half_rhythm"><div>Developmental evaluation</div></li><li class="half_rhythm"><div>Consultation with a clinical geneticist and/or genetic counselor</div></li></ul></div><div id="ssadh.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p>The management of SSADH deficiency is most often symptomatic, directed at the treatment of seizures and neurobehavioral disturbances.</p><p><b>Seizures.</b> Antiseizure medications employed for the treatment of SSADH deficiency tend to be broad spectrum, although valproate is avoided when possible because of inhibition of potential residual enzymatic activity [<a class="bk_pop" href="#ssadh.REF.shinka.2003.99">Shinka et al 2003</a>]. Vigabatrin, an irreversible inhibitor of GABA-transaminase, inhibits the formation of succinic semialdehyde [<a class="bk_pop" href="#ssadh.REF.matern.1996.313">Matern et al 1996</a>]. However, vigabatrin has shown inconsistent results [<a class="bk_pop" href="#ssadh.REF.howells.1992.181">Howells et al 1992</a>, <a class="bk_pop" href="#ssadh.REF.gropman.2003.s66">Gropman 2003</a>], suggesting that it is not effective at inhibiting peripheral GABA-transaminase, leading to a peripheral supply of 4-hydroxybutyric acid to the brain and thus decreasing its own efficacy. Brain MRI signal changes, particularly prominent in the thalamus and basal ganglia, have been seen in infants treated with relatively high doses of vigabatrin [<a class="bk_pop" href="#ssadh.REF.pearl.2009c.184">Pearl et al 2009c</a>].</p><p>However, reports of uncontrolled, nonblinded trials of vigabatrin in two <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> children described a decrease in plasma GHB concentrations and clinical improvement (specifically in verbal communication) in one child age eight years [<a class="bk_pop" href="#ssadh.REF.casarano.2012.119">Casarano et al 2012</a>] and slow clinical improvement (although not unexpected based on natural history) in a child age 2.5 years [<a class="bk_pop" href="#ssadh.REF.escalera.2010.128">Escalera et al 2010</a>].</p><p><b>Neurobehavioral symptoms.</b> Methylphenidate, thioridazine, risperidal, fluoxetine, and benzodiazepines have been used for the treatment of increased anxiety, aggressiveness, and inattention [<a class="bk_pop" href="#ssadh.REF.gibson.2003.763">Gibson et al 2003</a>].</p><p>Beneficial non-pharmacologic treatments include physical therapy directed at developing strength, endurance, and balance; occupational therapy for improvement of fine motor skills, feeding, and sensory integration; and speech therapy [<a class="bk_pop" href="#ssadh.REF.gropman.2003.s66">Gropman 2003</a>].</p></div><div id="ssadh.Surveillance"><h3>Surveillance</h3><p>Regular neurologic and developmental assessments are indicated.</p></div><div id="ssadh.AgentsCircumstances_to_Avoid"><h3>Agents/Circumstances to Avoid</h3><p>Valproate is generally contraindicated as it may inhibit residual SSADH enzyme activity [<a class="bk_pop" href="#ssadh.REF.shinka.2003.99">Shinka et al 2003</a>]. However, <a class="bk_pop" href="#ssadh.REF.vanadia.2013.133">Vanadia et al [2013]</a> reported an individual with SSADH deficiency who had refractory epilepsy after possible limbic encephalitis. The refractory epilepsy was finally controlled with magnesium valproate. One year after initiation of magnesium valproate therapy, the <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual remained seizure free and had marked behavioral improvements, including decreases in aggression, coprolalia, and non-recognition of danger. In addition, the EEG demonstrated improved background organization.</p></div><div id="ssadh.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>See <a href="#ssadh.Related_Genetic_Counseling_Issues">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="ssadh.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Biomarkers have been studied with plans for utilization in clinical trials. Positron emission tomography (PET) with [11C]flumazenil (FMZ), a benzodiazepine receptor antagonist, showed reduced binding in cortical, basal ganglia, and cerebellar regions of interest versus controls consistent with downregulation of GABA receptors [<a class="bk_pop" href="#ssadh.REF.pearl.2007.43">Pearl et al 2007</a>]. Transcranial magnetic stimulation similarly showed downregulation of GABAergic activity in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals versus controls [<a class="bk_pop" href="#ssadh.REF.pearl.2009a.343">Pearl et al 2009a</a>]. A single case of improvement in gait, coordination, and energy was reported as an abstract in a 30-month-old male administered 200 mg/kg/day of taurine [<a class="bk_pop" href="#ssadh.REF.saronwala.2008">Saronwala et al 2008</a>]. However, an open-label study of eighteen individuals with SSADH deficiency treated with taurine did not show significant improvement in adaptive behavior scores. This study was assigned a class IV level of evidence because it did not involve a control group [<a class="bk_pop" href="#ssadh.REF.pearl.2014.940">Pearl et al 2014</a>].</p><p>SGS-742, a GABA-B receptor antagonist, demonstrated in the murine model a significant effect on electrocorticography when compared with topiramate [<a class="bk_pop" href="#ssadh.REF.pearl.2009a.343">Pearl et al 2009a</a>]. Liver-mediated <a class="def" href="/books/n/gene/glossary/def-item/gene-therapy/">gene therapy</a> in the mouse model did lead to reductions in GHB levels in liver, kidney, serum, and brain extracts [<a class="bk_pop" href="#ssadh.REF.gupta.2004.527">Gupta et al 2004</a>]. A clinical trial of SGS-742 is currently enrolling (<a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a>).</p><p>Recent data demonstrated that administration of rapamycin to an SSADH-deficient mouse model reduced mTOR activity, reduced the elevated numbers of mitochondria in the liver and brain (due to improved mitophagy), and normalized aberrant antioxidant levels; mTOR inhibitors such as rapamycin may lead to the treatment of many diseases, including SSADH [<a class="bk_pop" href="#ssadh.REF.lakhani.2014.551">Lakhani et al 2014</a>].</p><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.ClinicalTrialsRegister.eu" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ClinicalTrialsRegister.eu</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions.</p></div><div id="ssadh.Other"><h3>Other</h3><p>Animal experiments utilizing the murine model have demonstrated partial efficacy involving the amino acid taurine, vigabatrin, and GABA<sub>B</sub> and GHB receptor inhibitors [<a class="bk_pop" href="#ssadh.REF.gupta.2004.527">Gupta et al 2004</a>].</p><p>A murine trial has demonstrated some efficacy of the ketogenic diet [<a class="bk_pop" href="#ssadh.REF.nylen.2008.449">Nylen et al 2008</a>], although the mechanism of the observed changes (and thus the potential for success in a human trial) is unknown [<a class="bk_pop" href="#ssadh.REF.knerr.2008.11">Knerr &#x00026; Pearl 2008</a>].</p></div></div><div id="ssadh.Genetic_Counseling"><h2 id="_ssadh_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="ssadh.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>Succinic semialdehyde dehydrogenase (SSADH) deficiency is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner.</p></div><div id="ssadh.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The parents of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> child are obligate heterozygotes (i.e., carriers of one <i>ALDH5A1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>).</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are typically asymptomatic. One report suggests that absence epilepsy with myoclonus and photosensitivity may be related to the <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> state [<a class="bk_pop" href="#ssadh.REF.dervent.2004.1417">Dervent et al 2004</a>].</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>At conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier.</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are typically asymptomatic.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The offspring of an individual with SSADH are obligate heterozygotes (carriers) for a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>ALDH5A1</i>.</p><p><b>Other family members of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Each sib of the proband's parents is at a 50% risk of being a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> of an <i>ALDH5A1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p></div><div id="ssadh.Carrier_Heterozygote_Detection"><h3>Carrier (Heterozygote) Detection</h3><p><b>Molecular genetic testing.</b> Carrier testing for at-risk relatives requires prior identification of the <i>ALDH5A1</i> pathogenic variants in the family.</p><p><b>Biochemical testing.</b> Carrier testing using biochemical testing is not accurate or reliable for <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> determination.</p></div><div id="ssadh.Related_Genetic_Counseling_Issues"><h3>Related Genetic Counseling Issues</h3><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk, clarification of <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> status, and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are carriers or are at risk of being carriers.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="ssadh.Prenatal_Testing_and_Preimplantati"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p><b>Molecular genetic testing.</b> Once the <i>ALDH5A1</i> pathogenic variants have been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> for SSADH deficiency are possible.</p><p><b>Biochemical testing.</b> 4-hydroxybutyric acid can be measured accurately in amniotic fluid by means of a sensitive stable-isotope dilution gas chromatography-mass spectrometry assay method using deuterium-labeled 4-hydroxybutyric acid as the internal standard [<a class="bk_pop" href="#ssadh.REF.gibson.2001">Gibson &#x00026; Jakobs 2001</a>].</p><p>SSADH enzyme activity can be measured in biopsied chorionic villus tissue and cultured amniocytes.</p><p><b>Molecular genetic and biochemical testing.</b> A combination of a metabolite analysis assay of enzyme activity with <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> increases the accuracy of prenatal testing [<a class="bk_pop" href="#ssadh.REF.hogema.2001.218">Hogema et al 2001</a>].</p></div></div><div id="ssadh.Resources"><h2 id="_ssadh_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>Succinic Semialdehyde Dehydrogenase Deficiency (SSADH) Association</b></div><div>498 Lillian Court</div><div>PO Box 180622</div><div>Delafield WI 53018</div><div><b>Phone:</b> 262-646-5133</div><div><b>Email:</b> ssadh@ssadh.net</div><div><a href="http://www.ssadh.net/site/c.ahJMLVMwGcK0E/b.8193477/k.B3DA/SSADH_Association.htm" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ssadh.net</a></div></li><li class="half_rhythm"><div><b>Association for Neuro-Metabolic Disorders (ANMD)</b></div><div>5223 Brookfield Lane</div><div>Sylvania OH 43560-1809</div><div><b>Phone:</b> 419-885-1809; 419-885-1497</div><div><b>Email:</b> volk4olks@aol.com</div></li><li class="half_rhythm"><div><b>Metabolic Support UK</b></div><div>5 Hilliards Court, Sandpiper Way</div><div>Chester Business Park</div><div>Chester CH4 9QP </div><div>United Kingdom</div><div><b>Phone:</b> 0845 241 2173</div><div><b>Email:</b> contact@metabolicsupportuk.org</div><div><a href="https://www.metabolicsupportuk.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.metabolicsupportuk.org</a></div></li></ul></div><div id="ssadh.Molecular_Genetics"><h2 id="_ssadh_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="ssadh.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>Succinic Semialdehyde Dehydrogenase Deficiency: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1195/table/ssadh.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__ssadh.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_ssadh.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_ssadh.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_ssadh.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_ssadh.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_ssadh.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_ssadh.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_ssadh.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/7915" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>ALDH5A1</i></a></td><td headers="hd_b_ssadh.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=7915" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">6p22<wbr style="display:inline-block"></wbr>​.3</a></td><td headers="hd_b_ssadh.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/P51649" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Succinate-semialdehyde dehydrogenase, mitochondrial</a></td><td headers="hd_b_ssadh.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.LOVD.nl/ALDH5A1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ALDH5A1 @ LOVD</a></td><td headers="hd_b_ssadh.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=ALDH5A1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ALDH5A1</a></td><td headers="hd_b_ssadh.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=ALDH5A1[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ALDH5A1</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="ssadh.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="ssadh.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for Succinic Semialdehyde Dehydrogenase Deficiency (<a href="/omim/271980,610045" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1195/table/ssadh.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__ssadh.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/271980" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">271980</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY; SSADHD</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/610045" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">610045</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">ALDEHYDE DEHYDROGENASE 5 FAMILY, MEMBER A1; ALDH5A1</td></tr></tbody></table></div></div><div id="ssadh.Molecular_Genetic_Pathogenesis"><h3>Molecular Genetic Pathogenesis</h3><p>Animal studies have shown loss of locomotor function following &#x003b3;-hydroxybutyrate (GHB) administration, reversible with inhibition of the mixed amino oxidase (MAO) system, consistent with a dopaminergic effect [<a class="bk_pop" href="#ssadh.REF.pearl.a">Pearl et al 2005a</a>]. Whether the cognitive, epileptic, neurobehavioral, and gait deficits in SSADH deficiency (as well as the extrapyramidal findings in ~10% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals) are related to chronically elevated endogenous GHB levels is uncertain.</p><p><a class="figpopup" href="/books/NBK1195/figure/ssadh.F1/?report=objectonly" target="object" rid-figpopup="figssadhF1" rid-ob="figobssadhF1">Figure 1</a> outlines the normal SSADH GABA degradative pathway. A murine model demonstrates downregulation and decreased function of the GABA<sub>A</sub> receptor, postulating an important role for GABA (gamma-aminobutyric acid) in the pathophysiology of at least the epileptic manifestations of SSADH deficiency [<a class="bk_pop" href="#ssadh.REF.wu.2006.42">Wu et al 2006</a>]. More specifically, <a class="bk_pop" href="#ssadh.REF.errington.2011.e19021">Errington et al [2011]</a> found that GABA<sub>A</sub> receptor-mediated inhibitory gain of function may be a common feature in murine models of typical absence seizures.</p><div class="iconblock whole_rhythm clearfix ten_col fig" id="figssadhF1" co-legend-rid="figlgndssadhF1"><a href="/books/NBK1195/figure/ssadh.F1/?report=objectonly" target="object" title="Figure 1. " class="img_link icnblk_img figpopup" rid-figpopup="figssadhF1" rid-ob="figobssadhF1"><img class="small-thumb" src="/books/NBK1195/bin/ssadh-Image001.gif" src-large="/books/NBK1195/bin/ssadh-Image001.jpg" alt="Figure 1. . In the absence of SSADH, transamination of &#x003b3;-aminobutyric acid (GABA) to succinic semialdehyde is followed by reduction to 4-hydroxybutyric acid (&#x003b3;-hydroxybutyrate [GHB])." /></a><div class="icnblk_cntnt" id="figlgndssadhF1"><h4 id="ssadh.F1"><a href="/books/NBK1195/figure/ssadh.F1/?report=objectonly" target="object" rid-ob="figobssadhF1">Figure 1. </a></h4><p class="float-caption no_bottom_margin">In the absence of SSADH, transamination of &#x003b3;-aminobutyric acid (GABA) to succinic semialdehyde is followed by reduction to 4-hydroxybutyric acid (&#x003b3;-hydroxybutyrate [GHB]). SSADH deficiency leads to significant accumulation of GHB and GABA. <a href="/books/NBK1195/figure/ssadh.F1/?report=objectonly" target="object" rid-ob="figobssadhF1">(more...)</a></p></div></div><p>A murine model demonstrated significant cerebral and cerebellar volume loss in <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> SSADH-deficient mutant mice while no differences in total brain volume were observed in <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> mice or wild type controls [<a class="bk_pop" href="#ssadh.REF.acosta.2010.1457">Acosta et al 2010</a>].</p><p>One case report described an individual who had early-onset SSADH with low-level glutathione (GSH), thus supporting the hypothesis of oxidative stress and mitochondrial dysfunction in SSADH deficiency that was previously described in in vitro studies [<a class="bk_pop" href="#ssadh.REF.niemi.2014.129">Niemi et al 2014</a>].</p><p><b>Gene structure.</b> The <i>ALDH5A1</i> transcript <a href="/nuccore/NM_000090.3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_000090.3</a> comprises ten exons distributed over 38 kb of <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> DNA. A longer transcript variant has been described. For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK1195/#ssadh.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Benign variants.</b> Of 27 novel variants identified in 48 unrelated families, six did not strongly affect enzymatic activity and were considered benign variants [<a class="bk_pop" href="#ssadh.REF.akaboshi.2003.442">Akaboshi et al 2003</a>].</p><p><b>Pathogenic variants.</b> A total of 44 pathogenic variants including <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splicing/">splicing</a> errors have been identified. No hotspots were detected [<a class="bk_pop" href="#ssadh.REF.akaboshi.2003.442">Akaboshi et al 2003</a>, <a class="bk_pop" href="#ssadh.REF.liu.2016.441">Liu et al 2016</a>]. <a class="bk_pop" href="#ssadh.REF.bekri.2004.347">Bekri et al [2004]</a> reported a 7-bp <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> in <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 10 in a family with an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> child having very low enzymatic activity and reported as having a mild but typical <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. <a class="bk_pop" href="#ssadh.REF.kwok.2012.280">Kwok et al [2012]</a> reported a novel 34-bp <a class="def" href="/books/n/gene/glossary/def-item/insertion/">insertion</a> in exon 10 that predicted a truncated SSADH protein lacking 50 amino acids in the C-terminus. Exon deletions have also been reported [<a class="bk_pop" href="#ssadh.REF.akaboshi.2003.442">Akaboshi et al 2003</a>].</p><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> GABA is metabolized to succinic acid by the sequential action of GABA-transaminase, in which GABA is converted to succinic semialdehyde, which then, by means of the enzyme succinic semialdehyde dehydrogenase, is oxidized to succinic acid.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> In the absence of succinic semialdehyde dehydrogenase, the transamination of GABA to succinic semialdehyde is quite likely followed by its reduction to GHB (gamma-hydroxybutyrate, a short monocarboxylic fatty acid whose role is unclear [<a class="bk_pop" href="#ssadh.REF.gupta.2003.s81">Gupta et al 2003</a>]. GHB, which accumulates in the urine, serum, and CSF of individuals with SSADH deficiency, has historically been considered the neurotoxic agent most responsible for the clinical manifestations of the disease [<a class="bk_pop" href="#ssadh.REF.pearl.a">Pearl et al 2005a</a>]. However, receptor studies in SSADH-deficient mice have shown alterations of GABA<sub>A</sub> and GABA<sub>B</sub> receptors but no alterations in GHB receptor binding or number, suggesting that the role of primary neurotoxin may be fulfilled by GABA [<a class="bk_pop" href="#ssadh.REF.vogel.2013.401">Vogel et al 2013</a>].</p><p><a class="bk_pop" href="#ssadh.REF.siggberg.2011.448">Siggberg et al [2011]</a> reported a family with developmental delay segregating a <a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> of 6p22.2 that included <i>ALDH5A1</i>. SSADH enzyme studies in cultured white cells revealed elevated SSADH activity, consistent with duplication as well as increased urinary SSA associated with oxidative stress. Hyperactive levels of SSADH activity may also have negative consequences for GABA metabolism and other metabolic sequences.</p><p>The main function of GHB in the central nervous system is the inhibition of presynaptic dopamine release. It is currently used to induce a model of absence in rodents and to control cateplexy and alcohol withdrawal syndromes; GHB is also a recreationally abused drug.</p></div></div><div id="ssadh.References"><h2 id="_ssadh_References_">References</h2><div id="ssadh.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="ssadh.REF.acosta.2010.1457">Acosta MT, Munasinghe J, Pearl PL, Gupta M, Finegersh A, Gibson KM, Theodore WH. Cerebellar atrophy in human and murine succinic semialdehyde dehydrogenase deficiency. <span><span class="ref-journal">J Child Neuro<em>l.</em> </span>2010;<span class="ref-vol">25</span>:1457–61.</span> [<a href="/pmc/articles/PMC3155424/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3155424</span></a>] [<a href="/pubmed/20445195" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20445195</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ssadh.REF.akaboshi.2003.442">Akaboshi S, Hogema BM, Novelletto A, Malaspina P, Salomons GS, Maropoulos GD, Jakobs C, Grompe M, Gibson KM. Mutational spectrum of the succinate semialdehyde dehydrogenase (ALDH5A1) gene and functional analysis of 27 novel disease-causing mutations in patients with SSADH deficiency. <span><span class="ref-journal">Hum Mutat. </span>2003;<span class="ref-vol">22</span>:442–50.</span> [<a href="/pubmed/14635103" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14635103</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ssadh.REF.alessa.2000.127">Al-Essa MA, Bakheet SM, Patay ZJ, Powe JE, Ozand PT. Clinical, fluorine-18 labeled 2-fluoro-2-deoxyglucose positron emission tomography (FDG PET), MRI of the brain and biochemical observations in a patient with 4-hydroxybutyric aciduria; a progressive neurometabolic disease. <span><span class="ref-journal">Brain Dev. </span>2000;<span class="ref-vol">22</span>:127–31.</span> [<a href="/pubmed/10722966" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10722966</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ssadh.REF.arnulf.2005.418">Arnulf I, Konofal E, Gibson KM, Rabier D, Beauvais P, Derenne JP, Philippe A. Effect of genetically caused excess of brain gamma-hydroxybutyric acid and GABA on sleep. <span><span class="ref-journal">Sleep. </span>2005;<span class="ref-vol">28</span>:418–24.</span> [<a href="/pubmed/16171286" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16171286</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ssadh.REF.bekri.2004.347">Bekri S, Fossoud C, Plaza G, Guenne A, Salomons GS, Jakobs C, Van Obberghen E. The molecular basis of succinic semialdehyde dehydrogenase deficiency in one family. <span><span class="ref-journal">Mol Genet Metab. </span>2004;<span class="ref-vol">81</span>:347–51.</span> [<a href="/pubmed/15059623" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15059623</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ssadh.REF.besse.2015.417">Besse A, Wu P, Bruni F, Donti T, Graham BH, Craigen WJ, McFarland R, Moretti P, Lalani S, Scott KL, Taylor RW, Bonnen PE. The GABA Transaminase, ABAT, is essential for mitochondrial nucleoside metabolism. <span><span class="ref-journal">Cell Metab. </span>2015;<span class="ref-vol">21</span>:417–27.</span> [<a href="/pmc/articles/PMC4757431/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4757431</span></a>] [<a href="/pubmed/25738457" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25738457</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ssadh.REF.casarano.2012.119">Casarano M, Alessandr&#x000ec; MG, Salomons GS, Moretti E, Jakobs C, Gibson KM, Cioni G, Battini R. Efficacy of vigabatrin intervention in a mild phenotypic expression of succinic semialdehyde dehydrogenase deficiency. <span><span class="ref-journal">JIMD Rep. </span>2012;<span class="ref-vol">2</span>:119–23.</span> [<a href="/pmc/articles/PMC3509850/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3509850</span></a>] [<a href="/pubmed/23430864" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23430864</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ssadh.REF.curtis.2001.350">Curtis AR, Fey C, Morris CM, Bindoff LA, Ince PG, Chinnery PF, Coulthard A, Jackson MJ, Jackson AP, McHale DP, Hay D, Barker WA, Markham AF, Bates D, Curtis A, Burn J. Mutation in the gene encoding ferritin light polypeptide causes dominant adult-onset basal ganglia disease. <span><span class="ref-journal">Nat Genet. </span>2001;<span class="ref-vol">28</span>:350–4.</span> [<a href="/pubmed/11438811" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11438811</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ssadh.REF.dervent.2004.1417">Dervent A, Gibson KM, Pearl PL, Salomons GS, Jakobs C, Yal&#x000e7;inkaya C. Photosensitive absence epilepsy with myoclonias and heterozygosity for succinic semialdehyde dehydrogenase (SSADH) deficiency. <span><span class="ref-journal">Clin Neurophysiol. </span>2004;<span class="ref-vol">115</span>:1417–22.</span> [<a href="/pubmed/15134710" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15134710</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ssadh.REF.errington.2011.e19021">Errington AC, Gibson KM, Crunelli V, Cope DW. Aberrant GABA(A) receptor-mediated inhibition in cortico-thalamic networks of succinic semialdehyde dehydrogenase deficient mice. <span><span class="ref-journal">PLoS One. </span>2011;<span class="ref-vol">6</span>:e19021.</span> [<a href="/pmc/articles/PMC3079762/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3079762</span></a>] [<a href="/pubmed/21526163" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21526163</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ssadh.REF.escalera.2010.128">Escalera GI, Ferrer I, Marina LC, Sala PR, Salomons GS, Jakobs C, P&#x000e9;rez-Cerd&#x000e1; C. Succinic semialdehyde dehydrogenase deficiency: decrease in 4-OH-butyric acid levels with low doses of vigabatrin. <span><span class="ref-journal">An Pediatr (Barc). </span>2010;<span class="ref-vol">72</span>:128–32.</span> [<a href="/pubmed/20018576" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20018576</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ssadh.REF.gibson.1997a.567">Gibson KM, Christensen E, Jakobs C, Fowler B, Clarke MA, Hammersen G, Raab K, Kobori J, Moosa A, Vollmer B, Rossier E, Iafolla AK, Matern D, Brouwer OF, Finkelstein J, Aksu F, Weber HP, Bakkeren JA, Gabreels FJ, Bluestone D, Barron TF, Beauvais P, Rabier D, Santos C, Lehnert W. The clinical phenotype of succinic semialdehyde dehydrogenase deficiency (4-hydroxybutyric aciduria): case reports of 23 new patients. <span><span class="ref-journal">Pediatrics. </span>1997a;<span class="ref-vol">99</span>:567–74.</span> [<a href="/pubmed/9093300" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9093300</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ssadh.REF.gibson.1997b.370">Gibson KM, Doskey AE, Rabier D, Jakobs C, Morlat C. Differing clinical presentation of succinic semialdehyde dehydrogenase deficiency in adolescent siblings from Lifu Island, New Caledonia. <span><span class="ref-journal">J Inherit Metab Dis. </span>1997b;<span class="ref-vol">20</span>:370–4.</span> [<a href="/pubmed/9266358" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9266358</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ssadh.REF.gibson.2003.763">Gibson KM, Gupta M, Pearl PL, Tuchman M, Vezina LG, Snead OC 3rd, Smit LM, Jakobs C. Significant behavioral disturbances in succinic semialdehyde dehydrogenase (SSADH) deficiency (gamma-hydroxybutyric aciduria). <span><span class="ref-journal">Biol Psychiatry. </span>2003;<span class="ref-vol">54</span>:763–8.</span> [<a href="/pubmed/14512218" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14512218</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ssadh.REF.gibson.2001">Gibson KM, Jakobs C. Disorders of beta- and alpha-amino acids in free and peptide-linked forms. In: Scriver CR, Beaudet AL, Sly WS, Valle D, Childs B, Kinzler KW, Vogelstein B, eds. <em>The Metabolic and Molecular Bases of Inherited Disease.</em> 8 ed. New York, NY: McGraw-Hill; 2001:2079-105.</div></li><li class="half_rhythm"><div class="bk_ref" id="ssadh.REF.gropman.2003.s66">Gropman A. Vigabatrin and newer interventions in succinic semialdehyde dehydrogenase deficiency. <span><span class="ref-journal">Ann Neurol. </span>2003;<span class="ref-vol">54</span> Suppl 6:S66–72.</span> [<a href="/pubmed/12891656" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12891656</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ssadh.REF.gupta.2003.s81">Gupta M, Hogema BM, Grompe M, Bottiglieri TG, Concas A, Biggio G, Sogliano C, Rigamonti AE, Pearl PL, Snead OC 3rd, Jakobs C, Gibson KM. Murine succinate semialdehyde dehydrogenase deficiency. <span><span class="ref-journal">Ann Neurol. </span>2003;<span class="ref-vol">54</span>:S81–90.</span> [<a href="/pubmed/12891658" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12891658</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ssadh.REF.gupta.2004.527">Gupta M, Jansen EE, Senephansiri H, Jakobs C, Snead OC, Grompe M, Gibson KM. Liver-directed adenoviral gene transfer in murine succinate semialdehyde dehydrogenase deficiency. <span><span class="ref-journal">Mol Ther. </span>2004;<span class="ref-vol">9</span>:527–39.</span> [<a href="/pubmed/15093183" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15093183</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ssadh.REF.hogema.2001.218">Hogema BM, Akaboshi S, Taylor M, Salomons GS, Jakobs C, Schutgens RB, Wilcken B, Worthington S, Maropoulos G, Grompe M, Gibson KM. Prenatal diagnosis of succinic semialdehyde dehydrogenase deficiency: increased accuracy employing DNA, enzyme, and metabolite analyses. <span><span class="ref-journal">Mol Genet Metab. </span>2001;<span class="ref-vol">72</span>:218–22.</span> [<a href="/pubmed/11243727" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11243727</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ssadh.REF.howells.1992.181">Howells D, Jakobs C, Kok RM, Wrennall J, Thompson GN. Vigabatrin therapy in succinic semialdehyde dehydrogenase deficiency. <span><span class="ref-journal">Mol Neuropharmacol. </span>1992;<span class="ref-vol">2</span>:181–4.</span></div></li><li class="half_rhythm"><div class="bk_ref" id="ssadh.REF.knerr.2008.598">Knerr I, Gibson KM, Jakobs C, Pearl PL. Neuropsychiatric morbidity in adolescent and adult succinic semialdehyde dehydrogenase deficiency patients. <span><span class="ref-journal">CNS Spectr. </span>2008;<span class="ref-vol">13</span>:598–605.</span> [<a href="/pmc/articles/PMC2562649/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2562649</span></a>] [<a href="/pubmed/18622364" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18622364</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ssadh.REF.knerr.2010.255">Knerr I, Gibson KM, Murdoch G, Salomons GS, Pope L, Jakobs C, Combs GA, Pearl PL. Neuropathology in succinic semialdehyde dehydrogenase deficiency. <span><span class="ref-journal">Pediatr Neurol. </span>2010;<span class="ref-vol">42</span>:255–8.</span> [<a href="/pmc/articles/PMC3155415/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3155415</span></a>] [<a href="/pubmed/20304328" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20304328</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ssadh.REF.knerr.2008.11">Knerr I, Pearl PL. Ketogenic diet: stoking energy stores and still posing questions. <span><span class="ref-journal">Exp Neurol. </span>2008;<span class="ref-vol">211</span>:11–3.</span> [<a href="/pubmed/18374334" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18374334</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ssadh.REF.kwok.2012.280">Kwok JS, Yuen CL, Law LK, Tang NL, Cherk SW, Yuen YP. A novel aldh5a1 mutation in a patient with succinic semialdehyde dehydrogenase deficiency. <span><span class="ref-journal">Pathology. </span>2012;<span class="ref-vol">44</span>:280–282.</span> [<a href="/pubmed/22437753" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22437753</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ssadh.REF.lakhani.2014.551">Lakhani R, Vogel KR, Till A, Liu J, Burnett SF, Gibson KM, Subramani S. Defects in GABA metabolism affect selective autophagy pathways and are alleviated by mTOR inhibition. <span><span class="ref-journal">EMBO Mol Med. </span>2014;<span class="ref-vol">6</span>:551–66.</span> [<a href="/pmc/articles/PMC3992080/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3992080</span></a>] [<a href="/pubmed/24578415" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24578415</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ssadh.REF.lapalmeremis.2015.861">Lapalme-Remis S, Lewis EC, De Meulemeester C, Chakraborty P, Gibson KM, Torres C, Guberman A, Salomons GS, Jakobs C, Ali-Ridha A, Parviz M, Pearl PL. Natural history of succinic semialdehyde dehydrogenase deficiency through adulthood. <span><span class="ref-journal">Neurology. </span>2015;<span class="ref-vol">85</span>:861–5.</span> [<a href="/pmc/articles/PMC4560056/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4560056</span></a>] [<a href="/pubmed/26268900" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26268900</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ssadh.REF.liu.2016.441">Liu N, Kong XD, Kan QC, Shi HR, Wu QH, Zhuo ZH, Bai QL, Jiang M. Mutation analysis and prenatal diagnosis in a Chinese family with succinic semialdehyde dehydrogenase and a systematic review of the literature of reported ALDH5A1 mutations. <span><span class="ref-journal">J Perinat Med. </span>2016;<span class="ref-vol">44</span>:441–51.</span> [<a href="/pubmed/25431891" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25431891</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ssadh.REF.matern.1996.313">Matern D, Lehnert W, Gibson KM, Korinthenberg R. Seizures in a boy with succinic semialdehyde dehydrogenase deficiency treated with vigabatrin (gamma-vinyl-GABA). <span><span class="ref-journal">J Inherit Metab Dis. </span>1996;<span class="ref-vol">19</span>:313–8.</span> [<a href="/pubmed/8803774" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8803774</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ssadh.REF.medinakauwe.1999.414">Medina-Kauwe LK, Tobin AJ, De Meirleir L, Jaeken J, Jakobs C, Nyhan WL, Gibson KM. 4-Aminobutyrate aminotransferase (GABA-transaminase) deficiency. <span><span class="ref-journal">J Inherit Metab Dis. </span>1999;<span class="ref-vol">22</span>:414–27.</span> [<a href="/pubmed/10407778" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10407778</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ssadh.REF.niemi.2014.129">Niemi AK, Brown C, Moore T, Enns GM, Cowan TM. Evidence of redox imbalance in a patient with succinic semialdehyde dehydrogenase deficiency. <span><span class="ref-journal">Mol Genet Metab Rep. </span>2014;<span class="ref-vol">1</span>:129–32.</span> [<a href="/pmc/articles/PMC5121295/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5121295</span></a>] [<a href="/pubmed/27896081" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27896081</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ssadh.REF.nylen.2008.449">Nylen K, Velazquez JL, Likhodii SS, Cortez MA, Shen L, Leshchenko Y, Adeli K, Gibson KM, Burnham WM, Snead OC 3rd. A ketogenic diet rescues the murine succinic semialdehyde dehydrogenase deficient phenotype. <span><span class="ref-journal">Exp Neurol. </span>2008;<span class="ref-vol">210</span>:449–57.</span> [<a href="/pmc/articles/PMC2362105/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2362105</span></a>] [<a href="/pubmed/18199435" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18199435</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ssadh.REF.pearl.a">Pearl PL, Acosta MT, Wallis DD, Bottiglieri T, Miotto K, Jakobs C, Gibson KM. Dyskinetic features of succinate semialdehyde dehydrogenase deficiency, a GABA degradative defect. In: Fern&#x000e1;ndez-Alvarez E, Arzimanoglou A, Tolosa E, eds. <em>Paediatric Movement Disorders: Progress in Understanding.</em> Surrey, UK: John Libbey Eurotext; 2005a:203-12.</div></li><li class="half_rhythm"><div class="bk_ref" id="ssadh.REF.pearl.2005b.1051">Pearl PL, Capp PK, Novotny EJ, Gibson KM. Inherited disorders of neurotransmitters in children and adults. <span><span class="ref-journal">Clin Biochem. </span>2005b;<span class="ref-vol">38</span>:1051–8.</span> [<a href="/pubmed/16298354" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16298354</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ssadh.REF.pearl.2004.107">Pearl PL, Gibson KM. Clinical aspects of the disorders of GABA metabolism in children. <span><span class="ref-journal">Curr Opin Neurol. </span>2004;<span class="ref-vol">17</span>:107–13.</span> [<a href="/pubmed/15021235" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15021235</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ssadh.REF.pearl.2009a.343">Pearl PL, Gibson KM, Cortez MA, Wu Y, Carter Snead O 3rd, Knerr I, Forester K, Pettiford JM, Jakobs C, Theodore WH. Succinic semialdehyde dehydrogenase deficiency: lessons from mice and men. <span><span class="ref-journal">J Inherit Metab Dis. </span>2009a;<span class="ref-vol">32</span>:343–52.</span> [<a href="/pmc/articles/PMC2693236/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2693236</span></a>] [<a href="/pubmed/19172412" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19172412</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ssadh.REF.pearl.2003.1413">Pearl PL, Gibson KM, Acosta MT, Vezina LG, Theodore WH, Rogawski MA, Novotny EJ, Gropman A, Conry JA, Berry GT, Tuchman M. Clinical spectrum of succinic semialdehyde dehydrogenase deficiency. <span><span class="ref-journal">Neurology. </span>2003;<span class="ref-vol">60</span>:1413–7.</span> [<a href="/pubmed/12743223" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12743223</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ssadh.REF.pearl.2014.940">Pearl PL, Schreiber J, Theodore WH, McCarter R, Barrios ES, Yu J, Wiggs E, He J, Gibson KM. Taurine trial in succinic semialdehyde dehydrogenase deficiency and elevated CNS GABA. <span><span class="ref-journal">Neurology. </span>2014;<span class="ref-vol">82</span>:940–4.</span> [<a href="/pmc/articles/PMC3963004/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3963004</span></a>] [<a href="/pubmed/24523482" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24523482</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ssadh.REF.pearl.2009b.1645">Pearl PL, Shamim S, Theodore WH, Gibson KM, Forester K, Combs SE, Lewin D, Dustin I, Reeves-Tyer P, Jakobs C, Sato S. Polysomnographic abnormalities in succinic semialdehyde dehydrogenase (SSADH) deficiency. <span><span class="ref-journal">Sleep. </span>2009b;<span class="ref-vol">32</span>:1645–8.</span> [<a href="/pmc/articles/PMC2786049/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2786049</span></a>] [<a href="/pubmed/20041601" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20041601</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ssadh.REF.pearl.2007.43">Pearl PL, Taylor JL, Trzcinski S, Sokohl A, Dustin I, Reeves-Tyer P, Herscovitch P, Carson R, Liew C, Shamim S, Quezado K, Gibson M, Theodore W. 11C-Flumazenil PET imaging in patients with SSADH deficiency. <span><span class="ref-journal">J Inherit Metab Dis. </span>2007;<span class="ref-vol">30</span> Suppl 1:43.</span></div></li><li class="half_rhythm"><div class="bk_ref" id="ssadh.REF.pearl.2009c.184">Pearl PL, Vezina LG, Saneto RP, McCarter R, Molloy-Wells E, Heffron A, Trzcinski S, McClintock WM, Conry JA, Elling NJ, Goodkin HP, Sotero de Menezes M, Ferri R, Gilles E, Kadom N, Gaillard W. Cerebral MRI abnormalities associated with vigabatrin therapy. <span><span class="ref-journal">Epilepsia. </span>2009c;<span class="ref-vol">50</span>:184–94.</span> [<a href="/pubmed/18783433" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18783433</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ssadh.REF.philippe.2004.564">Philippe A, Deron J, Genevieve D, de Lonlay P, Gibson KM, Rabier D, Munnich A. Neurodevelopmental pattern of succinic semialdehyde dehydrogenase deficiency (gamma-hydroxybutyric aciduria). <span><span class="ref-journal">Dev Med Child Neurol. </span>2004;<span class="ref-vol">46</span>:564–8.</span> [<a href="/pubmed/15287248" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15287248</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ssadh.REF.saronwala.2008">Saronwala A, Tournay A, Gargus, JJ. Taurine treatment of succinate semialdehyde dehydrogenase (SSADH) deficiency reverses MRI-documented globus lesion and clinical syndrome. Proc Am Coll Med Genet. 2008. Abstract.</div></li><li class="half_rhythm"><div class="bk_ref" id="ssadh.REF.shinka.2003.99">Shinka T, Ohfu M, Hirose S, Kuhara T. Effect of valproic acid on the urinary metabolic profile of a patient with succinic semialdehyde dehydrogenase deficiency. <span><span class="ref-journal">J Chromatogr B Analyt Technol Biomed Life Sci. </span>2003;<span class="ref-vol">792</span>:99–106.</span> [<a href="/pubmed/12829002" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12829002</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ssadh.REF.siggberg.2011.448">Siggberg L, Mustonen A, Schuit R, Salomons GS, Roos B, Gibson KM, Jakobs C, Ignatius J, Knuutila S. Familial 6p22.2 duplication associates with mild developmental delay and increased SSADH activity. <span><span class="ref-journal">Am J Med Genet B Neuropsychiatr Genet. </span>2011;<span class="ref-vol">156B</span>:448–53.</span> [<a href="/pmc/articles/PMC3082589/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3082589</span></a>] [<a href="/pubmed/21438145" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21438145</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ssadh.REF.tsuji.2010.85">Tsuji M, Aida N, Obata T, Tomiyasu M, Furuya N, Kurosawa K, Errami A, Gibson KM, Salomons GS, Jakobs C, Osaka H. A new case of GABA transaminase deficiency facilitated by proton MR spectroscopy. <span><span class="ref-journal">J Inherit Metab Dis. </span>2010;<span class="ref-vol">33</span>:85–90.</span> [<a href="/pmc/articles/PMC2828554/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2828554</span></a>] [<a href="/pubmed/20052547" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20052547</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ssadh.REF.vanadia.2013.133">Vanadia E, Gibson KM, Pearl PL, Trapolino E, Mangano S, Vanadia F. Therapeutic efficacy of magnesium valproate in succinic semialdehyde dehydrogenase deficiency. <span><span class="ref-journal">JIMD Rep. </span>2013;<span class="ref-vol">8</span>:133–7.</span> [<a href="/pmc/articles/PMC3565633/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3565633</span></a>] [<a href="/pubmed/23430529" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23430529</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ssadh.REF.vogel.2013.401">Vogel KR, Pearl PL, Theodore WH, McCarter RC, Jakobs C, Gibson KM. Thirty years beyond discovery--clinical trials in succinic semialdehyde dehydrogenase deficiency, a disorder of GABA metabolism. <span><span class="ref-journal">J Inherit Metab Dis. </span>2013;<span class="ref-vol">36</span>:401–10.</span> [<a href="/pmc/articles/PMC4349389/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4349389</span></a>] [<a href="/pubmed/22739941" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22739941</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ssadh.REF.wamelink.2011.216">Wamelink MM, Roos B, Jansen EE, Mulder MF, Gibson KM, Jakobs C. 4-Hydroxybutyric aciduria associated with catheter usage: a diagnostic pitfall in the identification of SSADH deficiency. <span><span class="ref-journal">Mol Genet Metab. </span>2011;<span class="ref-vol">102</span>:216–7.</span> [<a href="/pmc/articles/PMC3654524/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3654524</span></a>] [<a href="/pubmed/20965758" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20965758</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ssadh.REF.wang.2016.1305">Wang KY, Barker PB, Lin DD. A case of acute onset succinic semialdehyde dehydrogenase deficiency: neuroimaging findings and literature review. <span><span class="ref-journal">Childs Nerv Syst. </span>2016;<span class="ref-vol">32</span>:1305–9.</span> [<a href="/pubmed/26499347" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26499347</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ssadh.REF.wu.2006.42">Wu Y, Buzzi A, Frantseva M, Velazquez JP, Cortez M, Liu C, Shen L, Gibson KM, Snead OC 3rd. Status epilepticus in mice deficient for succinate semialdehyde dehydrogenase: GABAA receptor-mediated mechanisms. <span><span class="ref-journal">Ann Neurol. </span>2006;<span class="ref-vol">59</span>:42–52.</span> [<a href="/pubmed/16240371" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16240371</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ssadh.REF.yal_inkaya.2000.45">Yal&#x000e7;inkaya C, Gibson KM, G&#x000fc;nd&#x000fc;z E, Ko&#x000e7;er N, Fi&#x000e7;icio&#x0011f;lu C, K&#x000fc;&#x000e7;&#x000fc;kercan I. MRI findings in succinic semialdehyde dehydrogenase deficiency. <span><span class="ref-journal">Neuropediatrics. </span>2000;<span class="ref-vol">31</span>:45–6.</span> [<a href="/pubmed/10774997" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10774997</span></a>]</div></li></ul></div></div><div id="ssadh.Chapter_Notes"><h2 id="_ssadh_Chapter_Notes_">Chapter Notes</h2><div id="ssadh.Author_History"><h3>Author History</h3><p>Emily S Barrios; Children&#x02019;s National Medical Center (2013-2016)<br />Jessica L Cabalza; George Washington University (2006-2010) <br />Philip K Capp; George Washington University (2004-2006)
<br />Adrianne M Dorsey; Children&#x02019;s National Medical Center (2013-2016)<br />Ian Drillings; Children&#x02019;s National Medical Center (2010-2013)<br />Maciej Gasior, MD, PhD; National Institutes of Health (2004-2006)
<br />K Michael Gibson, PhD, FACMG (2004-present) <br />Thomas R Hartka, MS; George Washington University (2006-2010) <br />Phillip L Pearl, MD (2004-present) <br />Tom Reehal; Sheffield University (2010-2013)<br />Jean-Baptiste Roullet, PhD (2016-present)<br />Emily Robbins; George Washington University (2004-2006) <br />Natrujee Wiwattanadittakul, MD (2016-present)</p></div><div id="ssadh.Acknowledgments"><h3>Acknowledgments</h3><p>Supported in part by the NIH (NS 82286, NS 85369), Pediatric Neurotransmitter Diseases Association, March of Dimes National Birth Defects Foundation, and Partnership for Pediatric Epilepsy Research, including American Epilepsy Society, Epilepsy Foundation, Anna and Jim Fantaci, Fight Against Childhood Epilepsy and Seizures (FACES), Neurotherapy Ventures Charitable Research Fund, and Parents Against Childhood Epilepsy (PACE)</p></div><div id="ssadh.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>28 April 2016 (ma) Comprehensive update posted live</div></li><li class="half_rhythm"><div>19 September 2013 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>5 October 2010 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>25 July 2006 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>5 May 2004 (ca) Review posted live</div></li><li class="half_rhythm"><div>16 September 2003 (pp) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK1195</span><span class="label">PMID: <a href="/pubmed/20301374" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">20301374</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/stickler/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/iiae3/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK1195&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK1195/?report=reader">PubReader</a></li><li><a href="/books/NBK1195/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK1195" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK1195" style="display:none" title="Cite this Page"><div class="bk_tt">Pearl PL, Wiwattanadittakul N, Roullet JB, et al. Succinic Semialdehyde Dehydrogenase Deficiency. 2004 May 5 [Updated 2016 Apr 28]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK1195/pdf/Bookshelf_NBK1195.pdf">PDF version of this page</a> (446K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#ssadh.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#ssadh.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#ssadh.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#ssadh.Genetically_Related_Allelic_Disord" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#ssadh.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#ssadh.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#ssadh.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#ssadh.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#ssadh.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#ssadh.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#ssadh.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=7915[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">ALDH5A1</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=1485432" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=1485432" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=1485432" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=1485432" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/31117962" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Clinical diagnosis and mutation analysis of four Chinese families with succinic semialdehyde dehydrogenase deficiency.</a><span class="source">[BMC Med Genet. 2019]</span><div class="brieflinkpop offscreen_noflow">Clinical diagnosis and mutation analysis of four Chinese families with succinic semialdehyde dehydrogenase deficiency.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Wang P, Cai F, Cao L, Wang Y, Zou Q, Zhao P, Wang C, Zhang Y, Cai C, Shu J. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">BMC Med Genet. 2019 May 22; 20(1):88. Epub 2019 May 22.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301409" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Isolated Methylmalonic Acidemia</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Isolated Methylmalonic Acidemia<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Manoli I, Sloan JL, Venditti CP. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/12891656" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Vigabatrin and newer interventions in succinic semialdehyde dehydrogenase deficiency.</a><span class="source">[Ann Neurol. 2003]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Vigabatrin and newer interventions in succinic semialdehyde dehydrogenase deficiency.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Gropman A. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Ann Neurol. 2003; 54 Suppl 6:S66-72. </em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/9093300" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedarticles&amp;logdbfrom=pubmed">The clinical phenotype of succinic semialdehyde dehydrogenase deficiency (4-hydroxybutyric aciduria): case reports of 23 new patients.</a><span class="source">[Pediatrics. 1997]</span><div class="brieflinkpop offscreen_noflow">The clinical phenotype of succinic semialdehyde dehydrogenase deficiency (4-hydroxybutyric aciduria): case reports of 23 new patients.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Gibson KM, Christensen E, Jakobs C, Fowler B, Clarke MA, Hammersen G, Raab K, Kobori J, Moosa A, Vollmer B, et al. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Pediatrics. 1997 Apr; 99(4):567-74. </em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/12743223" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Clinical spectrum of succinic semialdehyde dehydrogenase deficiency.</a><span class="source">[Neurology. 2003]</span><div class="brieflinkpop offscreen_noflow">Clinical spectrum of succinic semialdehyde dehydrogenase deficiency.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Pearl PL, Gibson KM, Acosta MT, Vezina LG, Theodore WH, Rogawski MA, Novotny EJ, Gropman A, Conry JA, Berry GT, et al. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Neurology. 2003 May 13; 60(9):1413-7. </em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=20301374" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=20301374" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e040bf8dde089116939f6f5">Succinic Semialdehyde Dehydrogenase Deficiency - GeneReviews®</a><div class="ralinkpop offscreen_noflow">Succinic Semialdehyde Dehydrogenase Deficiency - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T20:25:12-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal101&amp;ncbi_phid=CE885F36E0403981000000000389011E&amp;ncbi_session=CE885F36E040BF71_0905SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK1195%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK1195&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK1195/&amp;ncbi_pagename=Succinic Semialdehyde Dehydrogenase Deficiency - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE885F36E040BF71_0905SID /projects/books/PBooks@5.22 portal101 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>